NCT06528418Recruiting
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Exploration and Study on the Identification of Various Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Source: ClinicalTrials.gov · Last updated 26 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecules. This model aims to accurately diagnose mutiple pulmonary diseases. The primary objectives it strives to accomplish are: 1. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose several common pulmonary diseases. 2. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose more pulmonary diseases.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 18 Jul 2024
- Start date
- 30 Jun 2024
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- ChromX Health
- Diseases
- Tuberculosis, Cystic fibrosis, Asthma, Pulmonary arterial hypertension, COPD, High blood pressure, Lung cancer
- NCT number
- NCT06528418
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 30 Jun 2024 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Individuals with a history of cancer other than lung disease.
- Individuals with other severe organic diseases or mental illnesses.
- Individuals with metabolic diseases such as diabetes, hyperlipidemia, etc.
- Any other condition that researchers deem unsuitable for participation in this clinical trial.
Other
- Pregnant women.
- Individuals who have undergone organ transplants or non-autologous (allogeneic) bone marrow or stem cell transplants.
Who the study is looking for
- Males or females, age must be 18 years old or above.
- Patients must meet the CT imaging diagnostic criteria for different lung diseases, and patients must be able to provide electronic versions of CT image data.
- Patients must have a clear clinical diagnosis.
- All participants must sign a written informed consent form.
Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Guangzhou Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.